Search Results - "Pallardó, L."

Diagnosis of acute cortical necrosis in renal transplantation by contrast-enhanced ultrasound: a preliminary experience by Fernandez, C P, Ripolles, T, Martinez, M J, Blay, J, Pallardó, L, Gavela, E

“…To evaluate the use of contrast-enhanced ultrasound (CEUS) for diagnosis of cortical necrosis in renal allografts. We reviewed the medical records and imaging…”
Get more information

Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody–Low Titers by Kanter Berga, J, Sancho Calabuig, A, Gavela Martinez, E, Puig Alcaraz, N, Avila Bernabeu, A, Crespo Albiach, J, Molina Vila, P, Beltrán Catalan, S, Pallardó Mateu, L

“…Abstract Background Kidney transplantation is the better option for end-stage renal disease (ESRD), but for patients with human leukocyte antigen (HLA)…”
Get full text

Delayed Graft Function After Renal Transplantation: An Unresolved Problem by Gavela Martínez, E, Pallardó Mateu, L.M, Sancho Calabuig, A, Beltrán Catalán, S, Kanter Berga, J, Ávila Bernabeu, A.I, Crespo Albiach, J

“…Abstract Unlike other areas in renal transplantation, delayed graft function (DGF) remains an apparently unavoidable complication owing to the characteristics…”
Get full text

Safety and Efficacy of Induction Treatment with Low Thymoglobulin Doses in Kidney Transplantation from Expanded-Criteria Donors by Sancho Calabuig, A, Gavela Martínez, E, Kanter Berga, J, Beltrán Calatán, S, Avila Bernabeu, A.I, Pallardó Mateu, L.M

“…Abstract Background Induction treatment has been recommended as part of the initial immunosuppressive regimen in kidney transplantation, and antithymocyte…”
Get full text

Beginning Hemodialysis: Do Patients With a Failed Renal Transplant Start in Worse Condition? by Beltrán, S, Gavela, E, Kanter, J, Sancho, A, Ávila, A, Górriz, J.L, Crespo, J.F, Pallardó, L.M

“…Abstract Objective Predialysis management of patients with kidney transplant failure is a topic of growing interest. Herein we have reviewed a group of…”
Get full text

Renal Allografts From Donors Older Than 70 Years Are Useful for Single Transplantation by Gavela, E, Pallardó, L.M, Ávila, A, Sancho, A, Beltrán, S, Kanter, J, Crespo, J.F

“…Abstract Kidney transplantation has been related in elderly recipients to a greater longevity compared with dialysis. Due to the scarcity of donors,…”
Get full text

Genetic Polymorphisms and Individualized Tacrolimus Dosing by López-Montenegro Soria, M.A, Kanter Berga, J, Beltrán Catalán, S, Milara Payá, J, Pallardó Mateu, L.M, Jiménez Torres, N.V

“…Abstract Background Genetic polymorphisms of metabolism enzymes or intestinal drug transporters may affect pharmacokinetic responses to immunosuppressive drugs…”
Get full text

Effect of Overweight on Kidney Transplantation Outcome by Sancho, A, Ávila, A, Gavela, E, Beltrán, S, Fernández-Nájera, J.E, Molina, P, Crespo, J.F, Pallardó, L.M

“…Abstract Introduction Obesity is a prevalent problem in renal transplant recipients that is followed by reduced graft and patient survivals. Because the…”
Get full text

Transplant Renal Artery Stenosis: Association With Acute Vascular Rejection by Fernández-Nájera, J.E., Beltrán, S., Aparicio, M., Molina, P., Gavela, E., Ávila, A., Sancho, A., Pallardó, L.M.

“…Transplant renal artery stenosis, the prevalence of which varies from 2% to 12%, is an important cause of hypertension and allograft dysfunction. We sought to…”
Get full text

Histological Findings of Early Graft Biopsies in Old Donor Renal Transplant Patients Receiving Induction Therapy by Gavela, E, Pallardó, L.M, Sancho, A, Ávilla, A, Beltrán, S, Roselló, E, Pérez, M.L, García, F

“…Abstract Since recipients of transplants from elderly donors are exposed to an increased risk of delayed graft function (DGF) and acute rejection episodes,…”
Get full text

Calcineurin Inhibitor Reduction Based on Maintenance Immunosuppression With Mycophenolate Mofetil in Renal Transplant Patients: POP Study by Pallardó, L.M, Oppenheimer, F, Guirado, L, Conesa, J, Hortal, L.J, Romero, R, Rivero, M, de Bonis, E, Muñiz, M.L, Esforzado, N

“…Abstract Since calcineurin inhibitors (CNI) have been introduced, they have become the cornerstone of immunosuppression for renal transplant patients, but…”
Get full text

Very Low-Grade Proteinuria at 3 Months Posttransplantation Is an Earlier Marker of Graft Survival by Sancho Calabuig, A, Pallardó Mateu, L.M, Avila Bernabeu, A.I, Gavela Martínez, E, Beltrán Catalán, S, Crespo Albiach, J.F

“…Abstract Proteinuria is an early finding that appears in the first 3 months after transplantation in half of patients. Frequently, it is very low grade (VLP;…”
Get full text

Influence of gestational diabetes mellitus on neonatal weight outcome in twin pregnancies by Guillén, M. A., Herranz, L., Barquiel, B., Hillman, N., Burgos, M. A., Pallardo, L. F.

“…Aims To evaluate the influence of gestational diabetes mellitus on neonatal birthweight, macrosomia and weight discrepancy in twin neonates. Methods An…”
Get full text

Benefits Derivated From Late Steroid Withdrawal in Renal Transplant Recipients by Gavela, E, Ávila, A, Sancho, A, Kanter, J, Beltrán, S, Crespo, J.F, Pallardó, L.M

“…Abstract Because corticosteroids have adverse metabolic effects, inducing bone-mineral imbalance and contributing to infections among renal transplant…”
Get full text

Induction Treatment With Low-Dose Thymoglobulin or Basiliximab in Renal Transplants From Older Donors by Gavela Martínez, E, Sancho Calabuig, A, Escudero Quesada, V, Ávila Bernabeu, A.I, Beltrán Catalán, S, Morales García, A.I, Crespo Albiach, J.F, Pallardó Mateu, L.M

“…Abstract Transplantation of kidneys from older donors is followed by an increase in delayed graft function (DGF) and acute rejection episodes (ARE). In these…”
Get full text

Use of Basiliximab Induction in Low–Immunological Risk Renal Transplant Recipients Receiving Tacrolimus-Based Immunosuppression by Gavela Martı́nez, E, Ávila Bernabeu, A.I, Sancho Calabuig, A, Beltrán Catalán, S, Escudero Quesada, V, Pallardó Mateu, L.M

“…Abstract Basiliximab induction treatment has been shown to reduce the incidence of acute rejection episodes without the secondary side effects observed with…”
Get full text

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1‐Year, Randomized Controlled Trial in Europe and Australasia by Salvadori, M., Budde, K., Charpentier, B., Klempnauer, J., Nashan, B., Pallardo, L. M., Eris, J., Schena, F. P., Eisenberger, U., Rostaing, L., Hmissi, A., Aradhye, S.

“…FTY720 is a novel immunomodulator investigated in de novo renal transplantation and other therapeutic areas including multiple sclerosis. This 1‐year…”
Get full text

Erythropoietin Treatment in the Sixth Posttransplant Month as a Prognostic Factor for Renal Allograft Survival by Molina, P., Gavela, E., Sancho, A., Ávila, A., Fernández-Nájera, J.E., Beltrán, S., Crespo, J.F., Pallardó, L.M.

“…The purpose of this work was to assess the prognostic value of the need for erythropoietin (EPO) treatment at 6 months after transplantation. We…”
Get full text

Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study by Morales, Jose Maria, Marcén, Roberto, del Castillo, Domingo, Andres, Amado, Gonzalez-Molina, Miguel, Oppenheimer, Federico, Serón, Daniel, Gil-Vernet, Salvador, Lampreave, Ildefonso, Gainza, Francisco Javier, Valdés, Francisco, Cabello, Mercedes, Anaya, Fernando, Escuin, Fernando, Arias, Manuel, Pallardó, Luis, Bustamante, Jesus

“…To describe the causes of graft loss, patient death and survival figures in kidney transplant patients in Spain based on the recipient's age. The results at 5…”
Get full text

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain by AGUADO, J. M, HERRERO, J. A, GAVALDA, J, TORRE-CISNEROS, J, BLANES, M, RUFI, G, MORENO, A, GURGUI, M, HAYEK, M, LUMBRERAS, C

“…Tuberculosis is unusual in transplant recipients. The incidence, clinical manifestations, and optimal treatment of this disease in this population has not been…”
Get full text